Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quest Pharmatech Inc V.QPT

Alternate Symbol(s):  QPTFF

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. It also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.


TSXV:QPT - Post by User

Comment by G1945Von Sep 29, 2022 7:47am
320 Views
Post# 34994213

RE:New Press Release - Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology License

RE:New Press Release - Quest PharmaTech Announces Sale of Bioceltran Investment and Return of Photodynamic Therapy Technology LicenseTo me, it looks like more disassembling of QPT's equity investments taking place by our leader.

First OncoQuest, for $300Mil (ya) where that lands no one knows. He even had to borrow $1 Mil for OncoQuest to be paid from future fortunes!! ??. Well we'll see.

Now sells Bioceltran for $300K with a down payment of $100K to keep our leader with cash for his survival. Waits 12 months for the balance. Are you kidding?

VPT to continue developing SL017 and SL052 on its own. Ya, and where is the money coming from for their development??


Our leader is looking out for his own survival as I see it, not us minions.

Our leader continuously does what is best for him.

Now let's wait for the next show to drop.


JMO
G1945V

<< Previous
Bullboard Posts
Next >>